HTGM
RARE's Seizure Study Fails, HTGM Soars After-hours, NTEC Awaits Data In Q3
Intec Pharma Ltd. ( NTEC ) has initiated a Phase I clinical trial of AP-CBD/THC, which is being developed for various indications,…
Intec Pharma Ltd. ( NTEC ) has initiated a Phase I clinical trial of AP-CBD/THC, which is being developed for various indications,…